CDEK
← All organizations

Viatris

For profit

Also known as: Investigational drug(Pretomanid) supported by Viatris Pharmaceutical | VIATRIS | Viatris Inc. | Viatris Innovation GmbH | Viatris Specialty LLC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Apr 30, 2021

First marketed drug

Jun 1, 1993

Last known activity

Dec 31, 2025

Acquired by Meda Pharmaceuticals → Mylan on Aug 8, 2005

Timeline

1990s

  1. Jul 31, 1992

    amlodipine— Marketing Organization

  2. Jul 31, 1992

    amlodipine— NDA Secondary Org

  3. Jun 1, 1993

    Viatris— Founded

2000s

  1. Aug 8, 2005

    Meda Pharmaceuticals— Acquired By

2010s

  1. Feb 10, 2016

    Mylan— Now

2020s

  1. Nov 7, 2022

    Oyster Point Pharma, Inc.Oyster Point Pharma, Inc.— Acquired

Drugs by trial phase (15 distinct, 22 trials)

Phase 4 (3 own, 1 via acquisition)

Phase 2 (0 own, 1 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Marketed drugs (12)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (14)

Details

Founded
Nottingham, GB Jun 1, 1993
Last known activity
Dec 31, 2025